Neuphoria Therapeutics Inc (NEUP)

Neuphoria Therapeutics Inc (NEUP) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $18.8M; returns 1 day -1.1%, 1 week +4.2%, 1 year -15.1%.

Neuphoria Therapeutics Inc. (formerly Bionomics Limited) is a clinical-stage biopharmaceutical company historically focused on developing small molecule allosteric ion channel modulators for central nervous system (CNS) and neuropsychiatric disorders.

Groups NEUP belongs to

• Biotechnology
• Clinical Stage Biopharma
• Healthcare
• Clinical Stage
• Neuroscience
• CNS Disorders
• Biopharmaceutical
• Clinical Stage Biotech
• Neurological Disorders

NEUP financial model: income statement, cash flow and balance sheet